Enlivex Therapeutics Ltd. Total Non Current Liabilities 2011-2026 | ENLV

Annual Total Non Current Liabilities Enlivex Therapeutics Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
299 K	686 K	4.19 M	5.39 M	499 K	298 K	198 K	-	-	70 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
5.39 M	70 K	1.45 M

Quarterly Total Non Current Liabilities Enlivex Therapeutics Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	5.39 M	-	405 K	-	499 K	-	236 K	-	298 K	-	-	-	198 K	-	-	-	351 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.39 M	198 K	1.05 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
AC Immune SA ACIU	9.24 M	$ 2.72	7.51 %	$ 229 M	Schweiz
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Aptorum Group Limited APM	2.21 M	$ 0.81	1.28 %	$ 4.42 M	China
I-Mab IMAB	131 M	-	-	$ 866 M	China
argenx SE ARGX	226 M	$ 840.28	1.7 %	$ 25 B	Niderland
Ascendis Pharma A/S ASND	101 M	$ 234.99	0.02 %	$ 5 B	Danmark
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.33	0.79 %	$ 8.01 B	Australia
Atea Pharmaceuticals AVIR	69.2 M	$ 4.65	1.31 %	$ 392 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	62.5 K	$ 1.25	-	$ 1.85 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
BioMarin Pharmaceutical BMRN	635 M	$ 62.62	-0.48 %	$ 11.9 B	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Capricor Therapeutics CAPR	4.86 M	$ 27.91	0.14 %	$ 747 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
CASI Pharmaceuticals CASI	38.2 M	$ 0.8	5.68 %	$ 109 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Catalyst Biosciences CBIO	981 K	$ 12.65	10.29 %	$ 833 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 169.95	-2.75 %	$ 8.45 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	9.03 B	$ 195.13	-0.62 %	$ 28.6 B	USA
Cellectis S.A. CLLS	109 M	$ 3.98	0.51 %	$ 116 M	France
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Baudax Bio BXRX	65.4 M	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Cellectar Biosciences CLRB	422 K	$ 3.36	3.07 %	$ 41.1 M	USA